Search

everythinglearnresearchcommunity

for

Search:↓

The compounds tested could potentially treat hair loss and alopecia.

Ultra-high molecular weight poly-γ-glutamic acid may help promote hair growth.

The study found nine new hair protein genes in human hair follicles.

Genetic testing is crucial for diagnosing rare hair loss disorders.

Only one K16 gene on chromosome 17 makes a functional keratin protein.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

The enzyme from human skin can cross-link proteins and needs calcium to work.

Lnc056 helps hair follicle stem cells grow by increasing TRIP6 expression.

A dissolving microneedle patch with collagen XVII effectively promotes hair regrowth in androgenic alopecia.

Keratin peptides in hair may help identify gender and ethnicity, but more research is needed.

Researchers found a new genetic mutation causing a rare hair loss condition in the first Japanese child studied.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

The excimer laser may help hair regrow in alopecia areata patients.

TRPS1 loss in balding scalp areas contributes to hair loss in androgenic alopecia.

The RNA AL136131.3 slows down hair growth and speeds up hair loss by affecting sugar breakdown in hair follicles.

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

The document's conclusion cannot be determined.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.